The effect on comorbidity and pain in patients with osteoarthritis

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 22, Issue 4, 2008, Pages 336-348

  Kirkness, Carmen S ^a   Yu, Junhua ^a   Asche, Carl V ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b Pharmacotherapy Outcomes Research Center   (United States)

Author keywords

Chronic disease; Comorbidity; Osteoarthritis; Pain

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAPSAICIN; DICLOFENAC; GLUCOCORTICOID; GROWTH FACTOR; IBUPROFEN; METALLOPROTEINASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; ROFECOXIB;

CHRONIC DISEASE; COMORBIDITY; DISABILITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MEDICAL DECISION MAKING; OSTEOARTHRITIS; PAIN; PRACTICE GUIDELINE; PREVALENCE; REVIEW;

CHRONIC DISEASE; CLINICAL PROTOCOLS; COMORBIDITY; COST OF ILLNESS; HUMANS; OSTEOARTHRITIS; PAIN; SEVERITY OF ILLNESS INDEX;

EID: 67650689316     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1080/15360280802536649     Document Type: Review

References (119)

1. Mensah G. Global and domestic health priorities: spotlight on chronic diseases. In: Atlanta, GA: Centers for Disease Control and Prevention; 2006.
2. Wu S-Y, Green A. Projection of chronic illness prevalence and cost. Inflation. 2000;October.
3. Federal Interagency Forum on Aging-related Statistics, National Center for Health Statistics. Data sources on older americans 2006. Hyattsville, MD; 2006.
4. Miller JF. Coping with Chronic Illness: Overcoming Powerlessness, 3rd ed. Philadelphia, PA: F.A. Davis; 2000.
5. Lubkin IM, Larsen, PD. Chronic Illness: Impact and Interventions, 5th ed. Sudbury, MA: Jones & Bartlett; 2002.
6. Partnership for Solutions. Chronic conditions: making the case of ongoing care. Robert Wood Johnson Foundation; September 2004 updates.
7. Smith C, Cowan C, Sensenig A, Catlin A. Health spending growth slows in 2003. Health Aff (Millwood). 2005;24:185-194.
8. Hoffman C, Rice D, Sung HY. Persons with chronic conditions. Their prevalence and costs. JAMA. 1996;276:1473-1479.
9. Wilper AP, Woolhandler S, Lasser KE, McCormick D, Bor DH, Himmelstein DU. A national study of chronic disease prevalence and access to care in uninsured U.S. adults. Ann Intern Med. 2008;149:170-176.
10. Ko Y, Coons SJ. An examination of self-reported chronic conditions and health status in the 2001 Medicare Health Outcomes Survey. Curr Med Res Opin. 2005;21:1801-1808.
11. Calkins E, Boult C, Wagner E, eds. New Ways to Care for Older People: Building Systems Based on Evidence. New York: Springer; 1999.
12. Wittink HM, Rogers WH, Lipman AG,etal. Older and younger adults in pain management programs in the United States: differences and similarities. Pain Med. 2006;7:151-163.
13. Stephen J. Morewitz MLG. Aging and Chronic Disorders. New York: Springer; 2007.
14. Charlson M, Charlson RF, Briggs W, Hollenberg J. Can disease management target patients most likely to generate high costs? The impact of comorbidity. J Gen Intern Med. 2007;22:464-469.
15. Muñoz E, Rosner F, Friedman R, Sterman H, Goldstein J, Wise L. Financial risk, hospital cost, and complications and comorbidities in medical non-complications and comorbidity-stratified diagnosis-related groups. Am J Med. 1988;84:933-939.
16. Kelsey JL, Hochberg MC. Epidemiology of chronic musculoskeletal disorders. Annu Rev Public Health. 1988;9:379-401.
17. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006;54:226-229.
18. OSTEOARTHRITIS. http://www.rheumatology. org/public/factsheets/oa-new. asp. Accessed Aug 18, 2008.
19. Dray A, Read SJ. Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther. 2007;9:212.
20. Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis - an untreatable disease? Nat Rev Drug Discov. 2005;4:331-344.
21. YelinE,Lubeck D,HolmanH,EpsteinW.The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthri-tis compared to controls. J Rheumatol. 1987;14:710-717.
22. de Bock GH, Kaptein AA, Touw-Otten F, Mulder JD. Health-related quality of life in patients with os-teoarthritis in a family practice setting. Arthritis Care Res. 1995;8:88-93.
23. Maurer K. Basic data on arthritis knee, hip, and sacroiliac joints in adults ages 25-74 years. Vital Health Stat 11. 1979(213):1-31.
24. Hunsche E, Chancellor JVM, Bruce N. The burden of arthritis and nonsteroidal anti-inflammatory treatment: a european literature review. PharmacoEconomics. 2001;19:1-15.
25. March LM, Bachmeier CJ. Economics of osteoarthritis: a global perspective. Baillieres Clin Rheumatol. 1997;11:817-834.
26. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis. 2004;63:395-401.
27. Kadam UT, Jordan K, Croft PR. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis. 2004;63:408-414.
28. Marks R. Obesity profiles with knee osteoarthritis: correlation with pain, disability, disease progression. Obesity. 2007;15:1867-1874.
29. Schellevis FG, van der Velden J, van de Lisdonk E, van Eijk JT, van Weel C. Comorbidity of chronic diseases in general practice. J Clin Epidemiol. 1993;46:469-473.
30. Sharma L, Kapoor D, Issa S. Epidemiology of osteoarthritis: an update. Curr Opin Rheumatol. 2006;18:147-156.
31. van den Akker M, Buntinx F, Roos S, Knottnerus JA. Problems in determining occurrence rates of multi-morbidity. J Clin Epidemiol. 2001;54:675-679.
32. Rochon PA, Katz JN, Morrow LA, et al. Comor-bid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care. 1996;34:1093-1101.
33. Gabriel SE, Crowson CS, O'Fallon WM. Comor-bidity in arthritis. J Rheumatol. 1999;26:2475-2479.
34. Stang PE, Brandenburg NA, Lane MC, Merikangas KR, Von Korff MR, Kessler RC. Mental and physical comorbid conditions and days in role among persons with arthritis. Psychosom Med. 2006;68:152-158.
35. Rozzini R, Frisoni GB, Ferrucci L, et al. Geriatric Index of Comorbidity: validation and comparison with other measures of comorbidity. Age Ageing. 2002;31:277-285.
36. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
37. Parmelee PA, Thuras PD, Katz IR, Lawton MP. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc. 1995;43:130-137.
38. Leong IY, Farrell MJ, Helme RD, Gibson SJ. The relationship between medical comorbidity and self-rated pain, mood disturbance, and function in older people with chronic pain. J Gerontol A Biol Sci Med Sci. 2007;62:550-555.
39. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661-674.
40. Fortin M, Dubois MF, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes. 2007;5:52.
41. Rigler SK, Studenski S, Wallace D, Reker DM, Duncan PW. Co-morbidity adjustment for functional outcomes in community-dwelling older adults. Clin Rehabil. 2002;16:420-428.
42. Verbrugge LM, Gates DM, Ike RW. Risk factors for disability among U.S. adults with arthritis. J Clin Epidemiol. 1991;44:167-182.
43. Ettinger WH, Davis MA, Neuhaus JM, Mallon KP. Long-term physical functioning in persons with knee osteoarthritis from NHANES. I: Effects of comorbid medical conditions. J Clin Epidemiol. 1994;47:809-815.
44. Weigl M, Angst F, Aeschlimann A, Lehmann S, Stucki G. Predictors for response to rehabilitation in patients with hip or knee osteoarthritis: a comparison of logistic regression models with three different definitions of responder. Osteoarthritis Cartilage. 2006;14:641-651.
45. Volpato S, Onder G, Cavalieri M, et al. Characteristics of nondisabled older patients developing new disability associated with medical illnesses and hospi-talization. J Gen Intern Med. 2007;22:668-674.
46. Cimmino MA, Sarzi-Puttini P, Scarpa R, et al. Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum. 2005;35(1 Suppl 1):17-23.
47. Witt CM, Jena S, Brinkhaus B, Liecker B, Wegscheider K, Willich SN. Acupuncture in patients with osteoarthritis of the knee or hip: a randomized, controlled trial with an additional nonrandomized arm. Arthritis Rheum. 2006;54:3485-3493.
48. Parazzini F, Cimmino MA, Sarzi-Puttini P, et al. The characteristics of symptomatic osteoarthritis in general and specialist practice in Italy: design and methods of the AMICA Study. Semin Arthritis Rheum. 2005;35(1 Suppl 1):11-16.
49. Caporali R, Cimmino MA, Sarzi-Puttini P, et al. Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists. Semin Arthritis Rheum. 2005;35(1 Suppl 1):31-37.
50. Schneider S, Schmitt G, Mau H, Schmitt H, Sabo D, Richter W. [Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey]. Orthopade. 2005;34:782-790.
51. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56:221-229.
52. Kane R. Understanding Health Care Outcomes Research, Vol 2, ed. Jones & Bartlett; 2005.
53. Ritzwoller DP, Crounse L, Shetterly S, Rublee D. The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord. 2006;7:72.
54. Tessier A, Finch L, Daskalopoulou SS, Mayo NE. Validation of the Charlson Comorbidity Index for predicting functional outcome of stroke. Arch Phys Med Rehabil. 2008;89:1276-1283.
55. van Dijk GM, Veenhof C, Schellevis F, et al. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Muscu-loskelet Disord. 2008;9:95.
56. Juhakoski R, Tenhonen S, Anttonen T, Kauppinen T, Arokoski JP. Factors affecting self-reported pain and physical function in patients with hip osteoarthritis. Arch Phys Med Rehabil. 2008;89:1066-1073.
57. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol. 1996;49:1407-1417.
58. Goldman N, Lin IF, Weinstein M, Lin YH. Evaluating the quality of self-reports of hypertension and diabetes. J Clin Epidemiol. 2003;56:148-154.
59. Kehoe R, Wu SY, Leske MC, Chylack LT Jr. Comparing self-reported and physician-reported medical history. Am J Epidemiol. 1994;139:813-818.
60. Dalstra JA, Kunst AE, Borrell C, et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol. 2005;34:316-326.
61. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbid-ity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
62. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622-626.
63. Gabriel SE, Crowson CS, O'Fallon WM. A comparison of two comorbidity instruments in arthritis. J Clin Epidemiol. 1999;52:1137-1142.
64. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
65. Cristovao de Souza R, Pinheiro RS, Coeli CM, Rochel de Camargo K Jr. The Charlson comorbidity index (CCI) for adjustment of hip fracture mortality in the elderly: analysis of the importance of recording secondary diagnoses. Cad Saude Publ. 2008;24:315-322.
66. Greenfield S, Aronow HU, Elashoff RM, Watanabe D. Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA. 1988;260:2253-2255.
67. Sales AE, Liu CF, Sloan KL, et al. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Med Care. 2003;41:753-760.
68. Sloan KL, Sales AE, Liu CF, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003;41:761-774.
69. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum Arthritis Care Res. 2005;53:666-672.
70. Hall SF, Groome PA, Streiner DL, Rochon PA. In-terrater reliability of measurements of comorbid illness should be reported. J Clin Epidemiol. 2006;59:926-933.
71. Gibofsky A, Barkin RL. Chronic pain of os-teoarthritis: considerations for selecting an extended-release opioid analgesic. Am J Ther. 2008;15:241-255.
72. Creamer P, Lethbridge-Cejku M, Hochberg MC. Where does it hurt? Pain localization in osteoarthritis of the knee. Osteoarthritis Cartilage. 1998;6:318-323.
73. Peloso PM. Opioid therapy for osteoarthritis of the hip and knee: use it or lose it? J Rheumatol. 2001;28:6-11.
74. Creamer P, Hochberg MC. Why does osteoarthritis of the knee hurt - sometimes? Br J Rheumatol. 1997;36:726-728.
75. Lohmander LS, Lark MW, Dahlberg L, Walakovits LA, Roos H. Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. Clin Biochem. 1992;25:167-174.
76. Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis. 1993;52:557-563.
77. Caspi D, Flusser G, Farber I, et al. Clinical, radiologic, demographic, and occupational aspects of hand osteoarthritis in the elderly. Semin Arthritis Rheum. 2001;30:321-331.
78. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27:1513-1517.
79. Felson DT, Lawrence RC, Hochberg MC, et al. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med. 2000;133:726-737.
80. Maetzel A, Makela M, Hawker G, Bombardier C. Osteoarthritis of the hip and knee and mechanical occupational exposure - a systematic overview of the evidence. J Rheumatol. 1997;24:1599-1607.
81. Cimmino MA, Sarzi-Puttini P, Scarpa R, et al. Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA study. Semin Arthritis Rheum. 2005;35(1 Suppl 1):17-23.
82. Hopman-Rock M, Odding E, Hofman A, Kraaimaat FW, Bijlsma JW. Differences in health status of older adults with pain in the hip or knee only and with additional mobility restricting conditions. J Rheumatol. 1997;24:2416-2423.
83. Hopman-Rock M, Westhoff MH. The effects of a health educational and exercise program for older adults with osteoarthritis for the hip or knee. J Rheumatol. 2000;27:1947-1954.
84. Caporali R, Cimmino MA, Sarzi-Puttini P, et al. Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists. Semin Arthritis Rheum. 2005;35:31-37.
85. Summers MN, Haley WE, Reveille JD, Alarcon GS. Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthritis Rheum. 1988;31:204-209.
86. Tukker A, Visscher T, Picavet H. Overweight and health problems of the lower extremities: osteoarthritis, pain and disability. Public Health Nutr. 2008;11:1-10.
87. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581-1586.
88. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
89. Ghione S. Hypertension-associated hypalgesia. Evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences. Hypertension. 1996;28:494-504.
90. Singh G, Miller JD, Lee FH, Pettitt D, Russell MW. Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. AmJManag Care. 2002;8(15 Suppl):S383-S391.
91. Dessein PH, Stanwix AE, Moomal Z. Rheumatoid arthritis and cardiovascular disease may share similar risk factors. Rheumatology. 2001;40:703-704.
92. Recommendations for the Medical Management of Osteoarthritis of the Hip and Knee. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. http://www.rheumatology.org/publications/ guidelines/oa-mgmt/oa- mgmt.asp#5. Accessed Aug 3, 2008.
93. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 1995;38:1541-1546.
94. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum. Nov. 1995;38:1535-1540.
95. Sarzi-Puttini P, Cimmino MA, Scarpa R, et al. Os-teoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum. 2005;35(1 Suppl 1):1-10.
96. Deal CL, Schnitzer TJ, LipsteinE,etal. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther. 1991;13:383-395.
97. Ravaud P, Moulinier L, Giraudeau B, et al. Effects of joint lavage and steroid injection in patients with os-teoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum. 1999;42:475-482.
98. Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A. 1996;93:14014-14019.
99. Yuan GH, Masuko-Hongo K, Kato T, Nishioka K. Immunologic intervention in the pathogenesis of osteoarthritis. Arthritis Rheum. 2003;48:602-611.
100. Kafienah W, Al-Fayez F, Hollander AP, Barker MD. Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach. Arthritis Rheum. 2003;48:709-718.
101. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283:1469-1475.
102. Jordan KM, Arden NK, DohertyM,etal. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145-1155.
103. Scott DL, Shipley M, Dawson A, Edwards S, Symmons DP, Woolf AD. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br J Rheumatol. 1998;37:546-554.
104. Bischoff HA, Roos EM. Effectiveness and safety of strengthening, aerobic, and coordination exercises for patients with osteoarthritis. Curr Opin Rheumatol. 2003;15:141-144.
105. Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal anti-inflammatory drug treatment. Arthritis Care Res. 1996;9:292-301.
106. Weinberger M, Tierney WM, Cowper PA, Katz BP, Booher PA. Cost-effectiveness of increased telephone contact for patients with osteoarthritis. Arandomized, controlled trial. Arthritis Rheum. 1993;36:243-246.
107. LeLorier J, Bombardier C, Burgess E, et al. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. Can J Cardiol. 2002;18:1301-1308.
108. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345:1809-1817.
109. MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet. 2003;361:573-574.
110. Roddy E, Zhang W, Doherty M, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee - the MOVE consensus. Rheumatology. 2005;44:67-73.
111. Rustoen T, Wahl AK, Hanestad BR, Lerdal A, Paul S, Miaskowski C. Age and the experience of chronic pain: differences in health and quality of life among younger, middle-aged, and older adults. Clin J Pain. 2005;21:513-523.
112. Wolz M, Cutler J, Roccella EJ, Rohde F, Thom T, Burt V. Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Am J Hypertens. 2000;13(1 Pt 1):103-104.
113. Roddy E, Zhang W, Doherty M. Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review. Ann Rheum Dis. 2005;64:544-548.
114. Terre L. The dialectic of tradition and progress in osteoarthritis management. Am J Lifestyle Med. 2007;1:3.
115. Williams A, Dunning T, Manias E. Continuity of care and general wellbeing of patients with co-morbidities requiring joint replacement. J Adv Nurs. 2007;57:244-256.
116. Rosemann T, Laux G, Szecsenyi J. Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. J Orthop Surg. 2007;2:12.
117. Saltzman CL, Zimmerman MB, O'Rourke M, Brown TD, Buckwalter JA, Johnston R. Impact of comorbidities on the measurement of health in patients with ankle osteoarthritis. J Bone Joint Surg Am. 2006;88:2366-2372.
118. Salaffi F, Carotti M, Grassi W. Health-related quality of life in patients with hip or knee osteoarthritis: comparison of generic and disease-specific instruments. Clin Rheumatol. 2005;24:29-37.
119. Jones CA, Voaklander DC, Suarez-Almazor ME. Determinants of function after total knee arthroplasty. Phys Ther. 2003;83:454-460.